Synopsis

A chilling story unfolds of a pharmaceutical company's relentless pursuit of profit, achieved through deceit and corruption. Insys Therapeutics, it is revealed, aggressively marketed a potent opioid painkiller, fifty times stronger than heroin, by bribing physicians and engaging in insurance fraud. An investigation by the Financial Times and FRONTLINE exposes the company's calculated strategy to maximize profits at the expense of public health. The report details how Insys Therapeutics profite